Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Operating Income (2016 - 2025)

Macrogenics (MGNX) has disclosed Operating Income for 14 consecutive years, with -$12.1 million as the latest value for Q4 2025.

  • Quarterly Operating Income rose 77.11% to -$12.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$72.8 million through Dec 2025, up 34.12% year-over-year, with the annual reading at -$72.8 million for FY2025, 34.13% up from the prior year.
  • Operating Income for Q4 2025 was -$12.1 million at Macrogenics, down from $18.6 million in the prior quarter.
  • The five-year high for Operating Income was $54.2 million in Q3 2024, with the low at -$66.6 million in Q1 2022.
  • Average Operating Income over 5 years is -$33.8 million, with a median of -$42.2 million recorded in 2022.
  • The sharpest move saw Operating Income plummeted 2583.69% in 2021, then skyrocketed 252.64% in 2024.
  • Over 5 years, Operating Income stood at -$58.2 million in 2021, then surged by 120.58% to $12.0 million in 2022, then crashed by 511.87% to -$49.4 million in 2023, then dropped by 7.06% to -$52.8 million in 2024, then surged by 77.11% to -$12.1 million in 2025.
  • According to Business Quant data, Operating Income over the past three periods came in at -$12.1 million, $18.6 million, and -$36.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.